HYPERBARIC OXYGEN THERAPY FOR THROMBOTIC COMPLICATIONS IN PATIENTS WITH ANTIPHOSPHOLIPID ANTIBODIES. Hasan A. Nogay1 & Maide Cimsit2. 1Department of Immunology, Institute for Experimental Medicine and Research & 2Department of Underwater and Hyperbaric Medicine, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey. INTRODUCTION: Circulating antiphospholipid antibodies (aPL) that activate vascular endothelial cells are associated with severe thrombosis, which is amenable to hyperbaric oxygen (HBO). The present study was conducted to describe the efficacy and benefit of HBO as an immunotherapy in patients with aPL-thrombosis syndrome. METHODS: Three female patients (aged 22 to 30 years) with central retinal artery occlusion (CRAO) and a 11 month old female with severe purpura fulminans (PF), who underwent HBO therapy were prospectively studied. On admission, two patients with CRAO had visual acuities with no light perception, while the third had light perception only. An average of 40 sessions of HBO were applied. RESULTS: In the patients with CRAO, vision improved an average of 3.6 visual acuity gradations. One patient with PF was cured with HBO and careful wound care. In this patient 1 digit spontaneously amputated and degenerated completely. CONCLUSIONS: We conclude that in combination with the other noninvasive treatment modalities, HBO should be administered as early as possible for thrombotic complications in patients with aPL-thrombosis syndrome Printed with Permission #hbot #oxygen #Rapidrecovery hbot4u 909 477 4545
Posted on: Mon, 27 Oct 2014 05:50:01 +0000
Trending Topics
Recently Viewed Topics
© 2015